Thursday, January 2, 2025
1/2/2025
SUMMARY This proposal describes experiments to investigate the role played by STRA6 in modulating transcription of genetic pathways in the RPE. Mutations in human STRA6 are associated with Matthew-Wood syndrome, whose symptoms include microphthalmia-anophthalmia, as well as pulmonary hypoplasia. STRA6 is found on the surface of many blood-tissue barrier epithelia, including the RPE. Though almost exclusively described as a retinoid transporter, STRA6 also is a cytokine signaling receptor, whose function in this role has only been studied in non-ocular tissues. This provokes exciting speculation into its role in the RPE of the eye: what molecular signaling is controlled by STRA6 in the RPE? How do the genes whose expression is modulated by STRA6 contribute to RPE function or survival? Which pathway(s) are important to maintain the health of the RPE, which sustains the photoreceptors? We will use zebrafish as a cone-rich model system to address these questions. Our proposed research has three Specific Aims: (1) to uncover molecular signaling important for RPE function whose expression is modulated by STRA6, (2) to dissect the contributions from individual signaling pathways to the RPE by making precise pathway-specific amino acid changes to STRA6, and (3) to inactivate genes whose expression is altered by STRA6 inactivation to understand their contribution to RPE function and survival. We have used CRISPR/Cas9 approaches to inactivate both STRA6 and its ligand RBP4 to profile their contribution to transcriptional modulation in the whole animal eye and in isolated human RPE culture. Together, our results will shed light on the under-appreciated role of STRA6 in RPE homeostasis and maintenance, while providing novel opportunities to develop treatment strategies to aid survival of RPE cells to prevent or combat retinal disease. This proposal directly addresses emerging needs outlined in “NEI Strategic Plan – Vision for the Future 2021-2025”. Specifically, we will i) address gaps in animal models, such as a model with a high density of cone photoreceptors; ii) explore strategies to treat complex disease such as modulating the expression of specific genes or gene editing; iii) examine the roles of redox biology and mitochondrial function in ocular health; and iv) identify ocular disease genes to develop new strategies, models, and tools for elucidating genetic and environmental interactions at the cellular and systems level, and thereby accelerate mechanistic understanding and therapy development.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).